https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/who-seeks-additional-clarifications-from-bharat-biotech-for-covaxin-to-conduct-final-risk-benefit-assessment/articleshow/87288732.cms
0
0
10/26/21 at 6:14pm
Organization
The Times of India
Author
PTI
The TAG met today (26 October 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine, the WHO said in an email response to a question by PTI on the decisi…
Create an account
or login to join the discussion